Predictive ability of the FLI for T2DM.

The fatty liver index (FLI) is a simple tool used to assess metabolic dysfunction-associated fatty liver disease (MAFLD). Previous studies have shown the utility of the FLI as an early predictor of diabetes for patients with prediabetes. We evaluated whether the FLI could predict the development of type 2 diabetes mellitus (T2DM) with normal glucose tolerance (NGT) by performing a retrospective assessment of a community-based cohort over the course of 18 years. We analyzed data of 6,083 adults with NGT available from the Korean Genome and Epidemiology Study database. Participants were stratified into the following three groups based on the FLI: low, FLI脂肪肝指数（fatty liver index, FLI）是一款用于评估代谢功能障碍相关性脂肪肝疾病（metabolic dysfunction-associated fatty liver disease, MAFLD）的简便评估工具。既往研究已证实，脂肪肝指数可作为前驱糖尿病患者罹患糖尿病的早期预测指标。本研究从韩国基因组与流行病学研究数据库中获取6083名糖耐量正常（normal glucose tolerance, NGT）的成年受试者数据，通过对一项为期18年的社区队列开展回顾性分析，旨在探究脂肪肝指数能否预测糖耐量正常人群的2型糖尿病（type 2 diabetes mellitus, T2DM）发病风险。研究对象依据脂肪肝指数水平被划分为以下三组：低水平组、[原文此处未完整呈现后续分组信息]